Syngene Biotechsp. z o.o.

Retail sale of medical and orthopaedic goods in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-04-17
Share capital
5,000.00 PLN
Activity description

Syngene Biotech is a company that specializes in equipping laboratories with high-quality scientific research equipment and provides diagnostic tests and reagents for molecular biology to diagnostic and scientific centers across Poland. They are the exclusive distributor in Poland for several brands, including Molecular Devices and Azure Biosystems, and have developed their own brand of reagents for DNA and RNA isolation and PCR reactions. Additionally, they offer technical support and consulting services.

Registered address
Ostródzka 13, 54-116 Wrocław, Poland
Website
Opening hours
Monday–Thursday
8:30–16:30
Friday
8:00–16:00
Social media

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 17 days early.

  • 202501/07/2026
  • 202416/06/2025
  • 202310/07/2024
  • 202212/07/2023
  • 202127/06/2022
  • 202014/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Offer

  • Laboratory equipment
  • Molecular biology reagents
  • Oligonucleotide synthesis
  • Gene synthesis
  • DNA sequencing
  • Genotyping

Website technology

Website
  • Drupal

Authorized Representatives

Iwona Anastazja Makuch – Attorney-in-fact
Małgorzata Chrabańska Ziętek – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the member of the management board. In the case of a management board consisting of two or more persons, joint action by two members of the management board or one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Małgorzata Chrabańska Ziętekage 61
50$1,350.62100%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Dec 21, 2021Dissolution without liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Solve Medicalsp. z o.o.
Medical Marketsp. z o.o.
Syngen Biotechsp. z o.o.
A-Biotechsp. z o.o.
Bio-Labsp. z o.o.
Medical Smart Integratorsp. z o.o.
Pergamonmedsp. z o.o.
Neoregensp. z o.o.
Espensp. z o.o.
Micomedsp. z o.o.

Change history

DateEvent
2022-05-26Name change
2022-05-26PKD change
2013-04-17Entered in the register

FAQ

Last updated: 2026-10-07